Page 163«..1020..162163164165..170180..»

Category Archives: Mesenchymal Stem Cells

International Cellular Medicine Society Grants First Worldwide Accreditation to Tijuana Clinical Trial

Posted: Published on February 29th, 2012

Regenerative Medicine Institute, Mexico has been granted full accreditation for its clinical stem cell trials Portland, Oregon (PRWEB) February 29, 2012 We are pleased that RMI undertook this process, says David Audley, executive director of the ICMS. The clinic understood that patient safety can only be assured through strict evaluation and rigorous oversight. From day one they have embraced the transparency that this program requires. RMI is the first clinic to achieve this status under the ICMS Accreditation Program. The clinic has undergone two separate site audits as well as an institutional review board review evaluation. Most importantly, the clinic has placed in excess of 50 patients into the Treatment Registry for long-term outcome tracking. The safety profile has been excellent, continued Audley. We have tracked patients over at least two follow-ups and a minimum of six months and not seen a single cell-related adverse event. The ICMS is currently evaluating nearly a dozen clinics worldwide. Accreditation is based upon the Guidelines for the Practice of Cell-Based Medicine developed and published by the ICMS. Key components of these guidelines are the ethical recruitment of patients, proper consent of patients and compliance with local laws and regulations in the treatment of … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on International Cellular Medicine Society Grants First Worldwide Accreditation to Tijuana Clinical Trial

Stem Cell Pioneers Converge in Portland to Discuss and Celebrate a Revolutionary New Stem Cell Entering Human Clinical …

Posted: Published on February 29th, 2012

SAN DIEGO, CA and PORTLAND, OR--(Marketwire -02/28/12)- Medistem Inc. (Pinksheets: MEDS.PK - News) announced today its Annual "Evening with Medistem" Event will take place in Portland, Oregon on March 7th, 2012. The event is being hosted by Vladimir Zaharchook, Vice Chairman at Medistem, Inc., and will feature stem cell luminaries and pioneers working with Medistem including Dr. Amit Patel, Director of Regenerative Medicine at University of Utah and the first person to administer stem cells into patients with heart failure, Dr. Michael Murphy, Vascular Surgeon at Indiana University and Principal Investigator for Medistem's FDA clinical trial in patients with risk of amputation, and Dr. Alan Lewis, former CEO of the Juvenile Diabetes Research Foundation, advisory board member of Medistem. In 2007 Medistem discovered an entirely new type of stem cell, the Endometrial Regenerative Cell (ERC). This cell has proven it is a "universal donor" and can be used to treat many more conditions compared to other types of stem cells. The company received FDA clearance to begin clinical trials in September of 2011 for critical limb ischemia, a condition that is associated with amputation. Medistem is also running a Phase II clinical trial for heart failure using the new stem … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Pioneers Converge in Portland to Discuss and Celebrate a Revolutionary New Stem Cell Entering Human Clinical …

Iranian researcher discovers factor of stem cell disorder

Posted: Published on February 29th, 2012

Source: ISNA, Tehran The researches have studied mesenchymal stem cells or MSCs derived from mice bone marrow in cell culture period and succeeded to identify new division in cell latency period which can lead to chromosomal disorders in the cells. Phd student in Hematology at Tarbiat Modarres University in Tehran, Naser Ahmad Beigi told ISNA that mesenchymal stem cells are powerful tools in cell therapeutic and tissue engineering because of their special specifications. For the same reasons stem cells derived from them are used effectively in experiments. He added during the procedure of separating mesenchymal stem cells from mice bone marrows, many researchers believe them to be dead and refuse to continue the procedure and this is because of changing form of the cells and a reduction in their propagation at the beginning level of the cell culture. Beigi stressed these signs show latency period and that cells would be propagated without showing any signs for a long time if the culture continues. He noted an unknown division is the specification of the latency period which leads to chromosomal disorders. He added the disorders can lead to the appearance of tumors inside the body and inefficiency of non-carcinogenic drugs and … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Iranian researcher discovers factor of stem cell disorder

Stem cell fertility treatments could be risky for older women

Posted: Published on February 28th, 2012

Harvard scientists are challenging traditional medical logic that dictates that women are born with a finite amount of eggs.  The scientists said they have discovered the ovaries of young women harbor rare stem cells that are in fact capable of producing new eggs. If properly harnessed, those stem cells may someday lead to new treatments for women suffering from infertility due to cancer or other diseases – or for those who are simply getting older, according to the researchers.  Lead researcher Jonathan Tilly of Harvard's Massachusetts General Hospital has co-founded a company, OvaScience Inc., to try to develop the findings into fertility treatments. The idea that women are born with all the egg cells – called oocytes – they’ll ever have has been called into question by past research, which found egg-producing stem cells in adult mice. In this latest study, Harvard researchers, in collaboration with Japanese scientists, used donated frozen ovaries from 20 year olds and ‘fished out’ the purported stem cells.   The researchers inserted a gene into the stem cells, which caused them to glow green.  If the cells produced eggs, those would glow green, too. The researchers first watched through a microscope as new eggs grew … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Stem cell fertility treatments could be risky for older women

StemCells, Inc. to Participate in Qatar International Conference on Stem Cell Science and Policy 2012

Posted: Published on February 28th, 2012

NEWARK, Calif., Feb. 27, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM - News) today announced that it will participate in the Qatar International Conference on Stem Cell Science and Policy, which is being held in Qatar from February 27 to March 1, 2012. The Company, which is the leader in development of cell-based therapeutics for central nervous system disorders, was specifically invited by the conference's sponsors, the State of Qatar and Amir of Qatar His Highness Sheikh Hamad bin Khalifa Al-Thani, as well as the James A. Baker III Institute for Public Policy of Rice University, and is the only company to be invited. Ann Tsukamoto, Ph.D., StemCells' Executive Vice President, Research and Development, will make a presentation on the clinical translation of human neural stem cells. StemCells was the first company to receive authorization from the US Food and Drug Administration to conduct a clinical trial of purified human neural stem cells, and the Company is currently conducting two clinical trials with a third anticipated to start later this year. Dr. Tsukamoto will also be the moderator of the panel session on neurological disorders, which is scheduled to be held on March 1 from 9:30 a.m. to 11:00 a.m. … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on StemCells, Inc. to Participate in Qatar International Conference on Stem Cell Science and Policy 2012

‘Scope for innovation in genetic medicine’

Posted: Published on February 28th, 2012

There is a tremendous opportunity in genetic medicine for innovation and for new players to make significant contributions, because it is still experimental, noted biologist and Nobel Laureate Dr David Baltimore said yesterday. “Today, it is mainly the province of biotechnology companies and universities, not big pharmaceutical companies,” he observed in a keynote presentation at the Qatar International Conference on Stem Cell Science and Policy 2012. There are new genetic tools available – though they are still experimental - to treat diseases which involve adding, subtracting or modifying genes in the cells of the body. “However, they are powerful tools and I am confident they will be an important part of the medicine of the future,” he said. Speaking on ‘The hematopoietic stem cell (HSC) as a target for therapy against cancer and Aids,’ Dr Baltimore explained that HSCs are one of the few cell types routinely used for bone marrow transplant. The HSCs are easily accessible, retroviruses can be used to carry genes into these stem cells, the genes are then expressed in all of cells that derive from the HSC and can correct inherited defects and bring genes that perform therapy under a programme called engineering immunity. “Though … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on ‘Scope for innovation in genetic medicine’

Bad breath being used in Stem Cell research

Posted: Published on February 28th, 2012

SALT LAKE CITY — Researchers may have found a use for the chemical that causes the stench in bad breath, stink bombs, and flatulence. This smelly substance known as Hydrogen Sulphide has been used in helping to convert stem cells from human teeth into liver cells. The scientists conducting the investigation and research in the Journal of Breath Research claim that the gas increased the purity of the stem cells. The goal is that the liver cells produced from the stem cells could be used for repair if the organ was damaged. Hydrogen Sulphide is produced by bacteria, and is toxic in large amounts. A group in China has reportedly tested the gas on rats to enhance the survival of mesenchymal stem cells taken from the bone marrow. Researchers from the Nippon Dental University were investigating stem cells from dental pulp — the material in the middle of the tooth. The dental pulp was taken from patients undergoing a routine tooth extraction. Dr. Ken Yaegaki, the lead author of the study, told the BBC why the dental pulp was so effective. "High purity means there are less 'wrong cells' that are being differentiated to other tissues, or remaining as stem … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Bad breath being used in Stem Cell research

Researchers Use Noxious Gas To Convert Stem Cells To Liver Cells

Posted: Published on February 28th, 2012

February 27, 2012 Japanese scientists have recently discovered that hydrogen sulfide (H2S) – the chemical responsible for such malodorous phenomena as human flatulence, bad breath and rotten eggs – can be used to efficiently convert stem cells from human teeth into liver cells. While the fetid chemical compound is produced in small quantities by the human body for use in a variety of biological signaling mechanisms, at high concentrations it is highly poisonous and extremely flammable. A team of researchers at the Nippon Dental University in Tokyo collected stem cells from the teeth of patients undergoing extractions. The cells were harvested from the central part of the tooth known as the pulp which is made up predominantly of connective tissue and cells. Stem cells recovered from the pulp were then divided into two groups and incubated in sealed chambers, one filled with hydrogen sulfide and the other a control group. The cells from each chamber were then examined at three-day intervals to look for signs of transformation into liver cells. One such indicator is the ability to store glycogen, a compound that can be converted to glucose when the body needs energy. According to a report of their findings that … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Researchers Use Noxious Gas To Convert Stem Cells To Liver Cells

Bad breath used as stem cell tool

Posted: Published on February 27th, 2012

27 February 2012 Last updated at 00:06 ET Hydrogen sulphide, the gas famed for generating the stench in stink bombs, flatulence and bad breath, has been harnessed by stem cell researchers in Japan. Their study, in the Journal of Breath Research, investigated using it to help convert stem cells from human teeth into liver cells. The scientists claimed the gas increased the purity of the stem cells. Small amounts of hydrogen sulphide are made by the body. It is also produced by bacteria and is toxic in large quantities. Therapy A group in China has already reported using the gas to enhance the survival of mesenchymal stem cells taken from the bone marrow of rats. Researchers at the Nippon Dental University were investigating stem cells from dental pulp - the bit in the middle of the tooth. They said using the gas increased the proportion of stem cells which were converted to liver cells when used alongside other chemicals. The idea is that liver cells produced from stem cells could be used to repair the organ if it was damaged. Dr Ken Yaegaki, from Nippon Dental University in Japan, said: "High purity means there are less 'wrong cells' that are … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Bad breath used as stem cell tool

Seminar to focus on stem cell research development

Posted: Published on February 27th, 2012

The latest discoveries and promises of stem cell research and the development of new therapeutic approaches for a variety of diseases will be in focus at the Qatar International Conference on Stem Cell Science and Policy 2012 which begins today. The four-day event, being held at Qatar National Convention Centre, is a milestone in Qatar Foundation’s ongoing collaboration with the James A Baker III Institute for Public Policy at Rice University, Houston, Texas, US. The aim of QF’s joint initiative with the Baker Institute’s International Programme on Stem Cell Science Policy is to develop stem cell research in Qatar as well as to find ways to address the shared challenges of community support for stem cell research in Doha and Houston. To accomplish this goal, the programme has supported several events since its inception, including meetings, workshops, and training programmes in both cities. The conference, which brings together eminent international as well as regional scientists, ethicists and policymakers, will also present the developed policy options that account for cultural, ethical and religious factors. The event will draw attention to Qatar’s position in the development of stem cell research in the region and the world, given that research on stem cell … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Seminar to focus on stem cell research development

Page 163«..1020..162163164165..170180..»

We cordially invite you to collaborate with us (as Speaker/Exhibitor/Sponsor/Media Partner) for “10th Annual Conference on Stem Cell and Regenerative Medicine” scheduled on August 13-14, 2018 in London, UK.

For meeting details visit: https://stemcell-regenerativemedicine.conferenceseries.com/